Original Article
Subject Category: Oligonucleotide Therapy
Molecular Therapy (2008) 17 1, 162–168 doi:10.1038/mt.2008.220
Chitosan/siRNA Nanoparticle–mediated TNF-
Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model
Kenneth A Howard1,2, Søren R Paludan3, Mark A Behlke4, Flemming Besenbacher1, Bent Deleuran3 and Jørgen Kjems1,2
- 1Interdisciplinary Nanoscience Center (iNANO), University of Aarhus, Aarhus C, Denmark
- 2Department of Molecular Biology, University of Aarhus, Aarhus C, Denmark
- 3Department of Medical Microbiology and Immunology, University of Aarhus, Aarhus C, Denmark
- 4Integrated DNA Technologies, Inc. Coralville, Iowa, USA
Correspondence: Kenneth A Howard, Interdisciplinary Nanoscience Center, Ny Munkegade, Building 521, University of Aarhus, DK-800 Aarhus C, Denmark. E-mail: kenh@inano.dk
Received 2 May 2008; Accepted 12 September 2008; Published online 30 September 2008.
Abstract
Secretion of tumor necrosis factor-
(TNF-
) by macrophages plays a predominant role in the development and progression of rheumatoid arthritis. We demonstrate that knockdown of TNF-
expression in systemic macrophages by intraperitoneal (i.p.) administration of chitosan/small interfering RNA (siRNA) nanoparticles in mice downregulates systemic and local inflammation. Chitosan nanoparticles containing an unmodified anti-TNF-
Dicer-substrate siRNA (DsiRNA) mediated TNF-
knockdown (~66%) in primary peritoneal macrophages in vitro. The presence of Cy3-labeled nanoparticles within peritoneal macrophages and specific TNF-
knockdown (~44%) with TNF-
siRNA after i.p. injection supports our therapeutic approach. Downregulation of TNF-
-induced inflammatory responses arrested joint swelling in collagen-induced arthritic (CIA) mice dosed i.p. with anti-TNF-
DsiRNA nanoparticles. The use of 2'-O-Me-modified DsiRNA resulted in the lowest arthritic scores and correlated with reduced type I interferon (IFN) activation in macrophages in vivo compared with unmodified DsiRNA. Histological analysis of joints revealed minimal cartilage destruction and inflammatory cell infiltration in anti-TNF-
-treated mice. The onset of arthritis could be delayed using a prophylactic dosing regime. This work demonstrates nanoparticle-mediated TNF-
knockdown in peritoneal macrophages as a method to reduce both local and systemic inflammation, thereby presenting a novel strategy for arthritis treatment.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
VIP: A very important protein in arthritisNature Medicine News and Views (01 May 2001)
RESEARCH
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteinsNature Immunology Article (01 Jun 2001)
Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivoNature Medicine Article (01 Aug 1995)
Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritisGene Therapy Research Article
See all 33 matches for Research
